Literature DB >> 18164036

Injury of the blood brain barrier and up-regulation of icam-1 in polymicrobial sepsis.

Stefan Hofer1, Christian Bopp, Christian Hoerner, Konstanze Plaschke, Rita M Faden, Eike Martin, Hubert J Bardenheuer, Markus A Weigand.   

Abstract

BACKGROUND: The pathogenesis and mechanisms of septic encephalopathy are not completely understood. We compared two different models of sepsis: lipopolysaccharide-induced endotoxemia and cecal ligation and puncture (CLP) bacteremia in rats with respect to changes in endothelial expression of the adhesion molecules intercellular adhesion molecule-1 (ICAM-1), platelet-endothelial cell adhesion molecule-1 (PECAM-1), and of cerebral albumin extravasation as a marker for capillary breakdown of the blood brain barrier.
MATERIAL AND METHODS: Male Wistar rats were divided into control, endotoxemia, or CLP-group. Mean arterial blood pressure was measured via femoral artery catheterization. Brain tissue for immunohistochemistry was harvested at 1 h, 6 h, and 24 h after induction of sepsis.
RESULTS: The CLP-group showed a decrease in mean arterial pressure after 24 h in comparison with the sham-group (P < 0.05). Cerebral ICAM-1 expression was at its maximum 24 h after induction of sepsis, with the highest expression in the CLP-group. There was no difference in PECAM-1 expression between the groups. Cerebral albumin extravasation increased early after 6 h in both septic groups with a maximum at 24 h after induction of sepsis.
CONCLUSION: These results suggest that there are early changes in the integrity of the blood-brain barrier in the central nervous system in an ongoing septic progress. This provides evidence that these changes are due to inflammatory mediators, and not to the presence of live bacteria. Increased ICAM-1 expression might be an early factor involved in these pathogenic events. Although the role of PECAM-1 cannot conclusively be determined, we were able to show its expression on cerebral endothelium in all groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164036     DOI: 10.1016/j.jss.2007.07.021

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  26 in total

1.  Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation.

Authors:  Mauricio Rosas-Ballina; Sergio I Valdés-Ferrer; Meghan E Dancho; Mahendar Ochani; David Katz; Kai Fan Cheng; Peder S Olofsson; Sangeeta S Chavan; Yousef Al-Abed; Kevin J Tracey; Valentin A Pavlov
Journal:  Brain Behav Immun       Date:  2014-07-23       Impact factor: 7.217

2.  Biomarkers of Delirium Duration and Delirium Severity in the ICU.

Authors:  Babar A Khan; Anthony J Perkins; Nagendra K Prasad; Anantha Shekhar; Noll L Campbell; Sujuan Gao; Sophia Wang; Sikandar H Khan; Edward R Marcantonio; Homer L Twigg; Malaz A Boustani
Journal:  Crit Care Med       Date:  2020-03       Impact factor: 7.598

Review 3.  Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis.

Authors:  Lucineia Gainski Danielski; Amanda Della Giustina; Marwa Badawy; Tatiana Barichello; João Quevedo; Felipe Dal-Pizzol; Fabrícia Petronilho
Journal:  Mol Neurobiol       Date:  2017-01-14       Impact factor: 5.590

Review 4.  Gut reactions: How the blood-brain barrier connects the microbiome and the brain.

Authors:  Aric F Logsdon; Michelle A Erickson; Elizabeth M Rhea; Therese S Salameh; William A Banks
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-23

5.  Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.

Authors:  Karl V Clemons; Julie A Schwartz; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

Review 6.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Circulating heparan sulfate fragments mediate septic cognitive dysfunction.

Authors:  Joseph A Hippensteel; Brian J Anderson; James E Orfila; Sarah A McMurtry; Robert M Dietz; Guowei Su; Joshay A Ford; Kaori Oshima; Yimu Yang; Fuming Zhang; Xiaorui Han; Yanlei Yu; Jian Liu; Robert J Linhardt; Nuala J Meyer; Paco S Herson; Eric P Schmidt
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

Review 8.  Cerebral perfusion in sepsis.

Authors:  Christoph S Burkhart; Martin Siegemund; Luzius A Steiner
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

9.  SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome.

Authors:  Vidula T Vachharajani; Tiefu Liu; Candice M Brown; Xianfeng Wang; Nancy L Buechler; Jonathan David Wells; Barbara K Yoza; Charles E McCall
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

10.  Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.

Authors:  Michael A Flierl; Philip F Stahel; Daniel Rittirsch; Markus Huber-Lang; Andreas D Niederbichler; L Marco Hoesel; Basel M Touban; Steven J Morgan; Wade R Smith; Peter A Ward; Kyros Ipaktchi
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.